Copyright thehindubusinessline
American life and science research company Thermo Fisher Scientific’s has expanded its R&D centre of excellence was inaugurated in Bengaluru. The company has invested over ₹160 crore in this expansion to add 37,000 sq. ft. facility. The Bengaluru facility has developed more than 2,000 high-quality recombinant antibodies that have contributed to advancements in infectious diseases, antiviral studies and cancer biology. Its antibody validation program has tested over 25,000 antibodies, while manufacturing capabilities have produced more than 2,000 primary and secondary antibodies, ensuring quality and reproducibility for researchers worldwide. Dignitaries present at the inauguration included senior officials from Karnataka Digital Economy Mission, KEONICS and the Karnataka Innovation & Technology Society (KITS). Also present were Gianluca Pettiti, Executive Vice President and Sector President, Life Sciences, Diagnostics and Applied Sector, Thermo Fisher Scientific; Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific; Manoj Prasad, Vice President, IT & Digital Solutions, APAC & MEA, Thermo Fisher Scientific; and other senior leaders from the company. Published on October 28, 2025
